Contineum Therapeutics, Inc. (CTNM) SEC Filings — 2024
14 SEC filings for Contineum Therapeutics, Inc. (CTNM) in 2024.
Filings
- Contineum Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 14, 2024
- Contineum Therapeutics Q3 2024: Net Loss and Cash Position — 10-Q · Nov 6, 2024
- Contineum Therapeutics Q2 2024: Cash Up, Expenses High — 10-Q · Aug 14, 2024
- Contineum Therapeutics Files 8-K on Financials — 8-K · Aug 13, 2024
- Contineum Therapeutics Appoints New CMO, CSO, and Directors — 8-K · Jun 24, 2024
- Contineum Therapeutics Appoints New CMO and CSO — 8-K · May 31, 2024
- Contineum Therapeutics Appoints New CMO & CSO — 8-K · May 20, 2024
- Contineum Therapeutics Files 10-Q for Q1 2024 — 10-Q · May 16, 2024
- Contineum Therapeutics, Inc. SC 13G Filing — SC 13G · Apr 15, 2024
- Contineum Therapeutics, Inc. SC 13G Filing — SC 13G · Apr 15, 2024
- Contineum Therapeutics, Inc. SC 13G Filing — SC 13G · Apr 10, 2024
- Contineum Therapeutics Files 8-K for Bylaws and Financials — 8-K · Apr 9, 2024
- Contineum Therapeutics Files Amendment to S-1 Registration Statement — S-1/A · Apr 1, 2024
- Contineum Therapeutics Files S-1 for Public Offering — S-1 · Mar 15, 2024